Study of HS-20117 Combination Therapy for Advanced Solid Tumors
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This early-phase trial tests a new drug (HS-20117) combined with other drugs for people with advanced solid tumors. It aims to see if the combination is safe and effective, especially for cancers that have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have advanced cancer (solid tumor) that has spread or cannot be removed by surgery, and at least one tumor that can be measured on a scan.
- You should be able to do your daily activities mostly on your own (ECOG 0-1) and have a life expectancy of at least 12 weeks.
- You cannot have had certain prior treatments, including drugs targeting MET or EGFR, or certain other cancer treatments within the last 2–4 weeks.
- You must not have active or untreated brain metastases, serious heart problems, or a serious infection in the last 4 weeks.
- You must be willing to use effective birth control during the study and not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, HS-20117, for people with advanced solid tumors, especially certain types of lung cancer. It aims to see if the drug is safe and effective when other treatments have stopped working.
This trial is testing an experimental drug called HS-20197 for people with advanced solid tumors (cancers that have spread or can't be removed). The goal is to see if it's safe and how well it works for a variety of solid tumor types.
This trial is testing a new drug called HS-20110 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This trial tests a new drug called HS-10370 given along with other anticancer treatments for advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if this combination is safe and effective for people who have run out of standard options.
This trial tests a new drug, HRS-7058, combined with other anti-cancer drugs for people with advanced solid tumors that cannot be surgically removed. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests a new combination treatment (HC010) for people with advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.